Asthma: RELVAR ELLIPTA is indicated for the maintenance treatment of asthma.
COPD: RELVAR ELLIPTA is indicated for the maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD) including chronic bronchitis and/or emphysema and to reduce exacerbations of COPD in patients with an exacerbation history.